News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syros Pharmaceuticals Announces Publication Of Important Scientific Studies Related To Company's Industry-Leading Gene Control Platform



12/18/2013 9:25:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that papers recently published by Syros Scientific Founders Richard A. Young, Ph.D., and James E. Bradner, M.D., in Cancer Cell and Nature Biotechnology provide further validation of the Syros scientific platform.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES